| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/06/2002 | CA2439185A1 Vector constructs |
| 09/06/2002 | CA2439115A1 Novel oncolytic adenoviral vectors |
| 09/06/2002 | CA2438960A1 Influenza vaccine formulations for intradermal delivery |
| 09/06/2002 | CA2430702A1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/05/2002 | US20020123471 Useful as a gene transfer vehicle for gene therapy, i.e. of the central nervous system |
| 09/05/2002 | US20020123458 Endostatin protein and fragments thereof |
| 09/05/2002 | US20020123038 Nucleotide sequences for use in the treatment of and prevention of viral infections |
| 09/04/2002 | EP1235912A2 Tumour-specific vector for gene therapy |
| 09/04/2002 | EP1235910A1 Plant virus particles with exogenous internal eitopes |
| 09/04/2002 | EP1235584A2 Virus immunologic determinants |
| 09/04/2002 | CN1090235C Method for purifying viruses by chromatography |
| 09/04/2002 | CN1090234C Analgesic health-care soap |
| 09/03/2002 | US6444871 Expression vector for use in the treatment and prevention of viral diseases |
| 09/03/2002 | US6444805 Recombinant human papillomavirus vaccine expressed in transgenic plants |
| 09/03/2002 | CA2232985C Methods for treating cancers and restenosis with p21 |
| 09/03/2002 | CA2228195C Transgenic insect virus for use as a biopesticide |
| 09/03/2002 | CA2160764C Fish pancreatic disease virus |
| 08/29/2002 | WO2002066629A2 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates |
| 08/29/2002 | WO2002066621A1 Attenuated live vaccine |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002003917A3 Alphavirus vectors and virosomes with modified hiv genes for use as vaccines |
| 08/29/2002 | WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 08/29/2002 | US20020120117 Polynucleotide that exhibits urothelial cell-specific transcriptional response element (TRE) activity; adenoviral vectors which replicate preferentially in urothelial cells; treating bladder cancer for example |
| 08/29/2002 | US20020119942 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/29/2002 | US20020119527 Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
| 08/29/2002 | US20020119447 Non-a,non-b,non-c,non-c,non-d,non-e hepatitis reagents and methods for their use |
| 08/29/2002 | US20020119445 Genetic engineering; prophylactic therapy |
| 08/29/2002 | CA2438322A1 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates |
| 08/28/2002 | EP1234048A2 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 08/28/2002 | EP1234024A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 08/28/2002 | EP1234023A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 08/28/2002 | EP1233783A2 Hbv/hcv virus-like particle |
| 08/28/2002 | CN1366053A Infective molecule cloning of low virulent vaccine strain for horse infective anemia virus |
| 08/28/2002 | CN1366041A Broad spectrum infectious chicken blader disease virus vaccine |
| 08/28/2002 | CN1366040A Recombinant virus of human vascular endothelial growth inhibitor |
| 08/27/2002 | US6440728 Making eukaryotic gene transfer vectors comprising homologous recombining lambdid vectors with a second dna in a bacterium; capsids; amplicons |
| 08/27/2002 | US6440718 Recombination to produce hepatitis a virus; gene expression |
| 08/27/2002 | US6440694 Which is a tumor necrosis factor (tnf) homolog of given nucleotide sequence and amino acid sequence |
| 08/27/2002 | US6440422 Expressing foreign genes inserted at site of naturally occurring deletion in modified vaccinia virus ankara genome; polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy; encoding antigens as vaccines |
| 08/22/2002 | WO2002064805A2 Replication competent non-mammalian retroviral vectors |
| 08/22/2002 | WO2002064757A2 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/22/2002 | WO2000023465A9 Methods and reagents for isolating biologically active peptides |
| 08/22/2002 | US20020115189 Generating genetically engineered, adeno-associated virons: obtain cells, transform with viral vector, express vector, recover transformed cells, culture cells and recover virons |
| 08/22/2002 | US20020115138 Nucleotide sequences coding transport protein for use in treat ment of tumors |
| 08/22/2002 | US20020114792 Alpha-2-macroglobulin therapies and drug screening methods for Alzheimer's disease |
| 08/21/2002 | EP1233062A2 Destabilisation of viral quasi-species distributions - avoiding resistance phenomena |
| 08/21/2002 | EP1233059A1 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/21/2002 | EP1232257A2 Modular transport systems for molecular substances and production and use thereof |
| 08/21/2002 | EP1232249A1 Duck pneumovirus and corresponding vaccines |
| 08/21/2002 | EP1232248A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 08/21/2002 | EP1231837A2 Preservation of sensitive biological material |
| 08/21/2002 | CN1365390A A human lactoferrin produced by using insect cell and method using the same |
| 08/21/2002 | CN1365388A Virus envelope vector for gene transfer |
| 08/20/2002 | US6437112 Dna encodes polypeptide of fusion protein or tail fiber proteins of bacteriophage t4 |
| 08/20/2002 | US6437095 Method for producing chimeric polypeptides |
| 08/20/2002 | US6436707 Trap cassette and splice acceptor; polyadenylation sequence defining 3' end of first exon; high speed screening; gene expression |
| 08/20/2002 | US6436702 Vaccines and antibodies to treat nervous necrosis virus in fish |
| 08/20/2002 | US6436693 Using dna helper virus vector dna mutated so that cis-acting signal sequences for packaging of dna are non-functional; helper virus dna may provide information necessary for production of viral particles but may not be packaged therein |
| 08/20/2002 | US6436408 Cold -adapted equine influenza viruses |
| 08/20/2002 | US6436402 Process for making human papillomavirus virus-like particles with improved properties |
| 08/20/2002 | US6436344 Method of inactivating pathogens |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2006865C Humanized immunoglobulins and their production and use |
| 08/15/2002 | WO2002062965A2 Method for identifying intercellular protein factors |
| 08/15/2002 | WO2002062827A2 Improved protein disaggregation and refolding using high pressure |
| 08/15/2002 | WO2002062296A2 Methods and compositions useful for stimulating an immune response |
| 08/15/2002 | WO2002024734A3 Influenza a virus haemagglutinin subtype h16 proteins and their encoding nuclei c acid |
| 08/15/2002 | WO2002018369A3 Peptidomimetic protease inhibitors |
| 08/15/2002 | WO2002006303A3 Dna vaccines encoding hiv accessory proteins |
| 08/15/2002 | US20020110896 Expression vector coding envelope protein for use in prevention and treatment of infections; for use in gene therapy |
| 08/15/2002 | US20020110866 Nucleotide sequences coding viral capsid protein; for use in the diagnosis, treatment and/or vaccination |
| 08/15/2002 | US20020110865 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 08/15/2002 | US20020110861 Expression vectors for use as tools for controlling gene expression in genetic engineering |
| 08/15/2002 | US20020110806 Detecting preferential biopolymer on solid support; generate solid support joined with bioploymer, incubate with bacteriophage, remove unbound phage, detecting replicated bound bacteriophage |
| 08/15/2002 | CA2434045A1 Improved protein disaggregation and refolding using high pressure |
| 08/14/2002 | EP1231269A1 Methods and compositions for polypeptide engineering |
| 08/14/2002 | EP1230354A2 Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 08/14/2002 | EP1230347A1 Method for the preparation of purified hcv rna by exosome separation |
| 08/14/2002 | EP0554389B2 Molecular clones of hiv-1 and uses thereof |
| 08/14/2002 | DE10158523A1 Hemmung der Transkription eines Zielgens in einer Zelle oder in Geweben Inhibition of transcription of a target gene in a cell or in tissue |
| 08/14/2002 | CN1364197A Vector for expressing two foreign genes |
| 08/14/2002 | CN1364195A Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 08/14/2002 | CN1364193A BHV-1 gene-deleted virus vaccine |
| 08/13/2002 | US6432699 Sindbis viral vectors for transducing target cells for gene encoding a chimeric envelope protein |
| 08/13/2002 | US6432653 Separation of cells from lymphs or myeloid linage with bonding and contacting cells |
| 08/13/2002 | CA2328851C Humanized immunoglobulins and their production and use |
| 08/08/2002 | WO2002061103A1 Method for obtaining packaging cells producing retrovirus by eliminating cells liable to be infected by the retrovirus produced |
| 08/08/2002 | WO2002061054A2 Method for increasing the virus propagation and the virus yield in cell cultures by blocking the activation of rnasel |
| 08/08/2002 | WO2002061048A2 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses |
| 08/08/2002 | WO2002060924A2 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
| 08/08/2002 | WO2002060553A1 Isolation of nanoparticles |
| 08/08/2002 | WO2002026192A3 Viruses targeted to hypoxic cells and tissues |
| 08/08/2002 | WO2002007742A3 Bacteriophage having multiple host range |
| 08/08/2002 | WO2002000885A3 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 08/08/2002 | WO2001092547A3 Modified bovine adenovirus having altered tropism |
| 08/08/2002 | WO2001091536A3 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 08/08/2002 | WO2001070941A3 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 08/08/2002 | WO2001016330A3 Prevention of affections associated with porcine circovirus-2 |
| 08/08/2002 | WO2001008703A9 Recombinant rsv virus expression systems and vaccines |
| 08/08/2002 | WO2000048703A9 Purification of biological substances |